Chronic CD40L blockade is required for long-term cardiac allograft survival with a clinically relevant CTLA4-Ig dosing regimen

IntroductionIn de-novo kidney transplantation, the CTLA4-Ig fusion protein belatacept is associated with improved graft function but also an increased risk of acute rejection compared to calcineurin inhibitor therapy. The combination with a second costimulation blocker could potentially improve outc...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Frontiers in Immunology
المؤلفون الرئيسيون: Lukas W. Unger, Moritz Muckenhuber, Benedikt Mahr, Christoph Schwarz, Nina Pilat, Nicolas Granofszky, Heinz Regele, Thomas Wekerle
التنسيق: مقال
اللغة:الإنجليزية
منشور في: Frontiers Media S.A. 2022-12-01
الموضوعات:
costimulation blockade
CTLA4Ig
CD40L blockade
murine cardiac allotransplant
transplantation
الوصول للمادة أونلاين:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1060576/full

الانترنت

https://www.frontiersin.org/articles/10.3389/fimmu.2022.1060576/full

مواد مشابهة